CHUNGBUK NATIONAL UNIVERSITY HOSPITAL
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- -
- Established
- 1988-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.cbnuh.or.kr/
Comparing Active Cycle of Breathing Techniques (ACBT) and Aerobika in Treating Bronchiectasis in Korea
Not Applicable
Not yet recruiting
- Conditions
- BronchiectasisBronchiectasis With Acute Exacerbation
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Chungbuk National University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT07037303
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
Efficacy and Safety of Remimazolam Compared With Midazolam During Bronchoscopy:Randomised Controlled Trial
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- Chungbuk National University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05994547
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: INS
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Chungbuk National University Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05103306
Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes
Phase 4
- Conditions
- Type 2 Diabetes MellitusGlucose, High Blood
- Interventions
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Chungbuk National University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04893148
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheonju, Chungcheongbuk-do, Korea, Republic of
Tepotinib in Solid Tumors Harboring MET Alterations
Phase 2
Recruiting
- Conditions
- Solid TumorMET Exon 14 Skipping MutationMET Amplification
- Interventions
- First Posted Date
- 2020-12-01
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Chungbuk National University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04647838
- Locations
- 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun, Chonnam, Korea, Republic of
🇰🇷Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
🇰🇷Dankook University Hospital, Cheonan, Korea, Republic of
Randomized Clinical Trial of HMR(Home Meal Replacement)-Type Omega-3-balanced-diet
Not Applicable
- Conditions
- Chronic Metabolic DisorderSarcopeniaLipid Metabolism Disorders
- Interventions
- Dietary Supplement: HMR(Home meal replacement)-type omega-3-balanced diet
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Chungbuk National University Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT04552574
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea, Republic of
Head-to-head Comparison of Empagliflozin and Dapagliflozin
- First Posted Date
- 2018-11-21
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Chungbuk National University Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT03748810
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheonju, Chungcheongbuk-do, Korea, Republic of
Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes
Completed
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2018-03-22
- Last Posted Date
- 2018-10-19
- Lead Sponsor
- Chungbuk National University Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT03473262